About Bluerock Healthcare Advisors
Over many decades, The Senior Team Members of Bluerock Healthcare´s Partners have been in a broad range of executive and advisory boards in the medical device, pharmaceutical and biotechnology industries. At Bluerock Healthcare we provide high level strategic and management advisory services to our clients. With our unique network, market access and expertise in different therapeutic areas, we offer customised product development & pipeline as well as business development strategies for international markets. We believe in and build upon long-term, trust-based relationships and we offer target oriented and focused strategy advisory as well as execution support.
The Bluerock Team
100+ YEARS OF COMBINED EXPERTISE
DR ACHIM SIMONS
Achim is a MD, and he is the Founder of Bluerock Healthcare. He has held various executive positions in the medtech, biotech and medical device industry since 2001, and has held positions as managing director and as a board member in different geographies since 2007. Achim has proven his unique ability to successfully launch and internationalize innovative medical devices and pharmaceuticals in different therapeutic areas. Achim oversaw several successful market-launches and expansion strategies with very strong revenue growth rates in the field of nephrology, orthopaedics, and endoscopy. Achim studied medicine at Heinrich Heine University in Düsseldorf, Germany and he doctorated in the field surgery. He also holds an Executive MBA from the University of Stellenbosch, South Africa.
DR CHRISTIAN KAPS
Christian has served as scientific and regulatory affairs expert in various senior positions in the biotech, pharmaceutical, and medical device industry. He has extensive experience in the field of different regulatory approval pathways in Europe, USA, and Asia. Christian is an expert in centralized, EMA-based as well as national approval processes in Europe, among others for advanced therapy medicinal products (ATMPs) and for innovative and combination medical devices. Christian was responsible for the successful EU authorization of the first German ATMP product in 2017. Christian has a strong understanding and expertise in the field of applied research and for developing innovative medical technologies. Christian studied biology and holds his PhD in Biology from the Technical University of Braunschweig, Germany.
DR ESZTER TANCZOS OLVER
Eszter is a MD and has over 25 years of experience as entrepreneur, CEO, and investor in the field of regenerative medicine and different innovative medical devices. Eszter led product developments, market launches and international expansions in different market segments inter alia in orthopaedics, maxillofacial surgery, dermatology, and plastic surgery. Eszter has strong skills in the development of business and international market strategies, in building and executing successful business plans, and in different stages of fundraising. Eszter has advised international companies in their business strategies, and she has been member of numerous executive boards. Eszter studied medicine at the Semmelweis University, Budapest, Hungary and at Albert Ludwig University Freiburg, Germany. She has also graduated at the Executive Program of the Singular University, Palo Alto, USA.
PROFESSOR JOACHIM BREUER
Joachim is internationally recognized as an expert on social security and social insurance and he was elected as the 16th President of the ISSA, the world's leading international organization for social security institutions, government departments and agencies. He served as Director General of the accident insurance and prevention institution for the German mining industry. He was also elected Director General of the German federation of institutions for statutory accident insurance and prevention (now the DGUV – German Social Accident Insurance). Joachim has advised several governments on the establishment of social insurance systems. He studies law at universities in Bonn and Berlin in Germany and he completed his doctorate in canon and civil law. Since 2018, he holds a professorship for Insurance Medicine at the University in Lübeck, Germany.
Expertise. Access. Trust.
Market Access & Business Development
Performance. Growth. Results.
Our customized market access, launch, and business development strategies help our clients to optimize their early or later stage marketing and sales activities in new markets. We offer lean, proven, and cost-effective strategies and provide operative support in different execution stages. We believe that building strong key opinion leader networks is crucial for innovative medical technologies. Therefore, we value our unique access to leading European and international scientific and clinical experts.